Viewing Study NCT05926518


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2025-12-26 @ 3:55 AM
Study NCT ID: NCT05926518
Status: COMPLETED
Last Update Posted: 2023-07-03
First Post: 2023-06-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients
Sponsor: Rijnstate Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module